Confidential Research Information. Subject to the provisions of Sections 3.3.2 and 9 regarding ownership of certain regulatory data and intellectual property, the parties agree that all results and data generated from the research and development by a party under the Agreement will be owned exclusively by that party and considered Confidential Information of that party subject to the confidentiality requirements of this Section 10. Firmenich will not provide to a Third Party any materials provided to it by Senomyx and Senomyx will not provide to a Third Party any materials provided to it by Firmenich. However, Firmenich may […***…].
Confidential Research Information. The parties agree that all results and data generated from the research under each Collaborative R&D Program will be owned exclusively by SENOMYX and, subject to the exceptions in Section 13.4, considered Confidential Information of SENOMYX, subject to the confidentiality requirements of Section 13. Accordingly, for the avoidance of doubt, the parties further agree that Senomyx shall have the authority to include any results and data that it generates in the course of each Collaborative R&D Program in any patent application , or in connection with the prosecution, maintenance or enforcement of any patent or patent application, or in connection with regulatory filings or other submissions to regulatory authorities without the prior consent or approval of PEPSICO. PEPSICO will not provide to a Third Party any Materials provided by SENOMYX to PEPSICO.
Confidential Research Information. Each party agrees that all results and data generated from the research under the Collaborative Program will be owned exclusively by the generating party and considered Confidential Information of the generating party subject to the confidentiality requirements of Section 12. Neither Kraft nor Senomyx will provide to a Third Party any Materials provided by the other party.
Confidential Research Information. The parties agree that information developed using an Assay Platform will be considered Confidential Information of both parties and shall be subject to the confidentiality requirements of this Article 7. Notwithstanding the foregoing, either party may disclose and use information developed using an Assay Platform that is not specific to a Target proposed by Senomyx for screen development and screening under an obligation of confidentiality to bona fide sublicensees.
Confidential Research Information. The parties agree that all results and data generated from the research by a party under the Collaborative Programs will be owned exclusively by that party and considered Confidential Information of that party subject to the confidentiality requirements of Section 10. Nestlé will not provide to a Third Party any Materials provided by Senomyx to Nestlé nor will Senomyx provide to a Third Party any Materials provided by Nestlé.
Confidential Research Information. The parties agree that all results and data generated from the research under the Collaborative R&D Program will be owned exclusively by SENOMYX and considered Confidential Information of SENOMYX subject to the confidentiality requirements of Section 14. KO will not provide to a Third Party any Materials provided by SENOMYX to KO.
Confidential Research Information. The parties agree that all results and data generated from the research under the Collaborative Program will be owned jointly by Senomyx and Xxxxxxxx to the extent of their respective contributions and considered Confidential Information of the parties subject to the confidentiality requirements of Section 10. Neither party will provide to a Third Party any Materials provided by the other or any Confidential Information without the express written consent of the other party.
Confidential Research Information. Subject to the provisions of Sections 3.5 and 8 regarding ownership of certain regulatory data and intellectual property, the parties agree that all results and data generated from the research and development by a party under [...***...] Program III will be owned [...***...] and considered Confidential ***Confidential Treatment Requested Information of [...***...] subject to the confidentiality requirements of this Section 9. Senomyx will not provide to a Third Party any [...***...] provided to it by [...***...]. Ajinomoto will not provide to a Third Party any [...***...] provided to it by Senomyx.
Confidential Research Information. Subject to the provisions of Sections 3.3 and 9 regarding ownership of certain regulatory data and intellectual property, the parties agree that all results and data generated from the research and development by a party under the Collaborative Program will be owned exclusively by that party and considered Confidential Information of that party subject to the confidentiality requirements of this Section 10. Solae will not provide to a Third Party any product samples or materials including, without limitation, Compounds provided to it by Senomyx and Senomyx will not provide to a Third Party any product samples or materials provided to it by Solae.
Confidential Research Information. Subject to the provisions of Sections 3.6 and 9 regarding ownership of certain regulatory data and intellectual property, the parties agree that all results and data generated from the research and development by a party under the Collaborative Program will be owned [***] and considered Confidential Information of [***] subject to the confidentiality requirements of the Section 10. Ajinomoto will not provide to a Third Party any materials including, without limitation, Substances provided to it by Senomyx and Senomyx will not provide to a Third Party any materials provided to it by Ajinomoto. ***Confidential Treatment Requested
